Heilongjiang Tianlong Pharmaceutical Company Ltd. Sustainability Profile
Heilongjiang Tianlong Pharmaceutical Company Ltd., commonly referred to as Tianlong Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in Harbin, Heilongjiang Province, China. Established in 1995, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of antibiotics and biopharmaceuticals. With a strong operational presence across various regions in China, Tianlong Pharmaceutical is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic medications and active pharmaceutical ingredients (APIs), distinguished by their efficacy and safety. Over the years, Tianlong has achieved notable milestones, solidifying its market position as a trusted provider in the healthcare sector, while continuously striving to enhance patient outcomes through advanced research and development initiatives.
DitchCarbon Score
How does Heilongjiang Tianlong Pharmaceutical Company Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Heilongjiang Tianlong Pharmaceutical Company Ltd.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Heilongjiang Tianlong Pharmaceutical Company Ltd.'s reported carbon emissions
Heilongjiang Tianlong Pharmaceutical Company Ltd., headquartered in China (CN), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. It is important to note that Heilongjiang Tianlong Pharmaceutical Company Ltd. is a current subsidiary, and any potential emissions data or climate initiatives may be cascaded from its parent organization. However, no specific information regarding such cascaded data or initiatives has been provided. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and climate action. As such, it is anticipated that Heilongjiang Tianlong Pharmaceutical Company Ltd. may develop and implement climate commitments in the future to align with industry standards and expectations.
How Carbon Intensive is Heilongjiang Tianlong Pharmaceutical Company Ltd.'s Industry?
How Carbon Intensive is Heilongjiang Tianlong Pharmaceutical Company Ltd.'s Location?
Heilongjiang Tianlong Pharmaceutical Company Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Heilongjiang Tianlong Pharmaceutical Company Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
